Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations

First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations This study uses pharmacoepidemiology data from Danish national health registries to examine the association between first-trimester exposure to modafinil and risk of major congenital malformations. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations

JAMA , Volume 323 (4) – Jan 28, 2020

Loading next page...
 
/lp/american-medical-association/first-trimester-pregnancy-exposure-to-modafinil-and-risk-of-congenital-4Sw69Bhq4u

References (4)

Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2019.20008
Publisher site
See Article on Publisher Site

Abstract

This study uses pharmacoepidemiology data from Danish national health registries to examine the association between first-trimester exposure to modafinil and risk of major congenital malformations.

Journal

JAMAAmerican Medical Association

Published: Jan 28, 2020

There are no references for this article.